MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Delcath Systems Retained Earnings 2011-2026 | DCTH
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Delcath Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -529 M | -532 M | -505 M | -457 M | -421 M | - | -371 M | -344 M | -325 M | -279 M | -261 M | -247 M | -229 M | -199 M | -147 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -147 M | -532 M | -346 M |
Quarterly Retained Earnings Delcath Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -527 M | -528 M | -530 M | -532 M | -528 M | -530 M | -516 M | -505 M | -494 M | -474 M | -466 M | -457 M | -447 M | -439 M | -429 M | -421 M | -416 M | -409 M | -402 M | -395 M | -395 M | -395 M | -395 M | -371 M | -371 M | -371 M | -371 M | -344 M | -344 M | -344 M | -344 M | -325 M | -325 M | -325 M | -325 M | -279 M | -279 M | -279 M | -279 M | -261 M | -261 M | -261 M | -261 M | -247 M | -247 M | -247 M | -247 M | -229 M | -229 M | -229 M | -229 M | -199 M | -199 M | -199 M | -199 M | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -199 M | -532 M | -357 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 11.1 | -0.72 % | $ 314 M |  USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Electromed
ELMD
|
21.2 M | $ 25.81 | 0.98 % | $ 218 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.16 | - | $ 1.31 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.45 | 3.29 % | $ 129 M |  France |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.61 | -2.42 % | $ 38 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 57.59 | -2.51 % | $ 3.14 B |  Britain |
 |
LENSAR
LNSR
|
-178 M | $ 5.48 | -1.44 % | $ 65.5 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 167.53 | -2.25 % | $ 11.8 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 48.25 | -12.02 % | $ 1.42 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.05 | -3.23 % | $ 17.8 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.42 | - | $ 6.71 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 17.04 | 7.98 % | $ 400 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.82 | -0.52 % | $ 1.02 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
TransMedics Group
TMDX
|
-278 M | $ 94.93 | -2.21 % | $ 3.23 B | USA |
 |
Tandem Diabetes Care
TNDM
|
-1.25 B | $ 19.42 | -2.26 % | $ 1.32 B | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 90.03 | -0.63 % | $ 12.2 B | USA |
 |
NanoVibronix
NAOV
|
-90.5 M | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.64 | 2.12 % | $ 1.14 B | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 295.25 | 1.5 % | $ 113 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 85.85 | 2.26 % | $ 2.98 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 82.91 | -0.5 % | $ 48.5 B | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.27 | -4.51 % | $ 51.7 M | USA |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 3.64 | 0.83 % | $ 538 M | USA |
 |
Myomo
MYO
|
-119 M | $ 0.88 | 1.69 % | $ 36.8 M | USA |